A Phase II, Single-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Therapeutic Efficacy of Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer’s Disease

Michael Rosenbloom, Terry R. Barclay, Bhavani Kashyap, Lyndsay M. Hage, Lauren R O'Keefe, Aleta L. Svitak, Maria Pyle, William H. Frey, Leah R. Hanson